These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12832673)

  • 41. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
    Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
    Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice.
    Sachs AP; Koëter GH; Groenier KH; van der Waaij D; Schiphuis J; Meyboom-de Jong B
    Thorax; 1995 Jul; 50(7):758-63. PubMed ID: 7570411
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.
    Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B;
    Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.
    File TM; Mandell LA; Tillotson G; Kostov K; Georgiev O
    J Antimicrob Chemother; 2007 Jul; 60(1):112-20. PubMed ID: 17537866
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis.
    McCarty JM; Pierce PF
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):327-34. PubMed ID: 11686426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Symptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitis.
    Woolhouse IS; Hill SL; Stockley RA
    Thorax; 2001 Dec; 56(12):947-53. PubMed ID: 11713358
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Five-day telithromycin once daily is as effective as 10-day clarithromycin twice daily for the treatment of acute exacerbations of chronic bronchitis and is associated with reduced health-care resource utilization.
    Fogarty C; de Wet R; Mandell L; Chang J; Rangaraju M; Nusrat R
    Chest; 2005 Oct; 128(4):1980-8. PubMed ID: 16236845
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of chronic bronchitis and COPD.
    Anzueto A; Miravitlles M; Ewig S; Legnani D; Heldner S; Stauch K
    Respir Med; 2012 Sep; 106(9):1258-67. PubMed ID: 22749710
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Update on the use of levofloxacin in the management of acute exacerbations of chronic bronchitis with risk factors].
    Zuck P
    Presse Med; 2002 Jun; 31(21 Pt 2):S15-8. PubMed ID: 12148385
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A multinational, multicentre, non-blinded, randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitis.
    Schaberg T; Ballin I; Huchon G; Bassaris H; Hampel B; Reimnitz P;
    J Int Med Res; 2001; 29(4):314-28. PubMed ID: 11675905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical effectiveness and safety of gemifloxacin versus cefpodoxime in acute exacerbation of chronic bronchitis: A randomized, controlled trial.
    Chatterjee S; Biswas T; Dutta A; Sengupta G; Mitra A; Kundu S
    Indian J Pharmacol; 2011 Feb; 43(1):40-4. PubMed ID: 21455420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Esberitox N as supportive therapy when providing standard antibiotic treatment in subjects with a severe bacterial infection (acute exacerbation of chronic bronchitis). A multicentric, prospective, double-blind, placebo-controlled study.
    Hauke W; Köhler G; Henneicke-Von Zepelin HH; Freudenstein J
    Chemotherapy; 2002 Dec; 48(5):259-66. PubMed ID: 12476043
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute exacerbations of chronic bronchitis. Preventing treatment failures and early reinfection.
    Verghese A; Ismail HM
    Postgrad Med; 1994 Dec; 96(8):75-6, 79-82, 87-9. PubMed ID: 7991479
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The association of lung function and St. George's respiratory questionnaire with exacerbations in COPD: a systematic literature review and regression analysis.
    Martin AL; Marvel J; Fahrbach K; Cadarette SM; Wilcox TK; Donohue JF
    Respir Res; 2016 Apr; 17():40. PubMed ID: 27084761
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Shinzato T; Doyle E; Edelstein MA
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2204-9. PubMed ID: 11451675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short-course fluoroquinolones in acute exacerbations of chronic bronchitis.
    Gotfried MH; Grossman RF
    Expert Rev Respir Med; 2010 Oct; 4(5):661-72. PubMed ID: 20923343
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Beeh KM; Beier J; Candler H; Wittig T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gemifloxacin. Factive, LB 20304, SB 265805.
    Drugs R D; 2002; 3(4):258-70. PubMed ID: 12455202
    [No Abstract]   [Full Text] [Related]  

  • 59. A critical review of the fluoroquinolones: focus on respiratory infections.
    Zhanel GG; Ennis K; Vercaigne L; Walkty A; Gin AS; Embil J; Smith H; Hoban DJ
    Drugs; 2002; 62(1):13-59. PubMed ID: 11790155
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
    Nalepa P; Dobryniewska M; Busman T; Notario G
    Curr Med Res Opin; 2003; 19(5):411-20. PubMed ID: 13678478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.